关注
Eva JA Morris
Eva JA Morris
在 ndph.ox.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer …
MP Coleman, D Forman, H Bryant, J Butler, B Rachet, C Maringe, U Nur, ...
The Lancet 377 (9760), 127-138, 2011
14922011
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England
MM Mafham, E Spata, R Goldacre, D Gair, P Curnow, M Bray, S Hollings, ...
The Lancet 396 (10248), 381-389, 2020
7342020
Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study
NP West, EJA Morris, O Rotimi, A Cairns, PJ Finan, P Quirke
The lancet oncology 9 (9), 857-865, 2008
5602008
Global trends in colorectal cancer mortality: projections to the year 2035
M Araghi, I Soerjomataram, M Jenkins, J Brierley, E Morris, F Bray, ...
International journal of cancer 144 (12), 2992-3000, 2019
4942019
Surgical management and outcomes of colorectal cancer liver metastases
EJA Morris, D Forman, JD Thomas, P Quirke, EF Taylor, L Fairley, ...
Journal of British Surgery 97 (7), 1110-1118, 2010
4202010
Palliative biliary stents for obstructing pancreatic carcinoma
AC Moss, E Morris, P MacMathuna
Cochrane database of systematic reviews, 2006
3952006
Thirty-day postoperative mortality after colorectal cancer surgery in England
EJA Morris, EF Taylor, JD Thomas, P Quirke, PJ Finan, MP Coleman, ...
Gut 60 (6), 806-813, 2011
3462011
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study
EJA Morris, R Goldacre, E Spata, M Mafham, PJ Finan, J Shelton, ...
The lancet Gastroenterology & hepatology 6 (3), 199-208, 2021
3232021
World Endoscopy Organization consensus statements on post-colonoscopy and post-imaging colorectal cancer
MD Rutter, I Beintaris, R Valori, HM Chiu, DA Corley, M Cuatrecasas, ...
Gastroenterology 155 (3), 909-925. e3, 2018
2792018
Reporting colorectal cancer
P Quirke, E Morris
Histopathology 50 (1), 103-112, 2007
2762007
Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results
AC Moss, E Morris, J Leyden, P MacMathuna
Cancer treatment reviews 33 (2), 213-221, 2007
2732007
Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000–2007
C Maringe, S Walters, B Rachet, J Butler, T Fields, P Finan, R Maxwell, ...
Acta oncologica 52 (5), 919-932, 2013
2502013
Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction
AC Moss, E Morris, J Leyden, P MacMathuna
European journal of gastroenterology & hepatology 19 (12), 1119-1124, 2007
2472007
Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene?
E Morris, P Quirke, JD Thomas, L Fairley, B Cottier, D Forman
Gut 57 (12), 1690-1697, 2008
2202008
Emergency presentation of cancer and short-term mortality
S McPhail, L Elliss-Brookes, J Shelton, A Ives, M Greenslade, S Vernon, ...
British journal of cancer 109 (8), 2027-2034, 2013
2092013
Identifying stage III colorectal cancer patients: the influence of the patient, surgeon, and pathologist
EJA Morris, NJ Maughan, D Forman, P Quirke
Journal of clinical oncology 25 (18), 2573-2579, 2007
1702007
Post-colonoscopy colorectal cancer (PCCRC) rates vary considerably depending on the method used to calculate them: a retrospective observational population-based study of PCCRC …
EJA Morris, MD Rutter, PJ Finan, JD Thomas, R Valori
Gut 64 (8), 1248-1256, 2015
1672015
Health-related quality of life after colorectal cancer in England: a patient-reported outcomes study of individuals 12 to 36 months after diagnosis
A Downing, EJA Morris, M Richards, J Corner, P Wright, ...
Journal of clinical oncology 33 (6), 616-624, 2015
1652015
High hospital research participation and improved colorectal cancer survival outcomes: a population-based study
A Downing, EJA Morris, N Corrigan, D Sebag-Montefiore, PJ Finan, ...
Gut 66 (1), 89-96, 2017
1642017
Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology
EJA Morris, NJ Maughan, D Forman, P Quirke
Gut 56 (10), 1419-1425, 2007
1622007
系统目前无法执行此操作,请稍后再试。
文章 1–20